Photodynamic therapy for Barrett's esophagus and high grade dysplasia: results of a patient satisfaction survey

Gastroenterol Nurs. 2002 Jul-Aug;25(4):139-41. doi: 10.1097/00001610-200207000-00002.

Abstract

There are few data available describing the experience of patients who have undergone photodynamic therapy with porfimer sodium for Barrett's esophagus. We describe the results of a satisfaction survey reported by 16 of 18 patients (11 men, 5 women; median age 75 years; median response at 27 months after treatment) treated with photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Treatments were performed on an outpatient basis although two patients required clinic visits for intravenous fluids. Subjects reported their most significant post-treatment problem was odynophagia or dysphagia (75%), which was best treated with a hydrocodone bitartrate and acetaminophen elixir (75%). Cutaneous photosensitivity persisted for a median of six weeks; two patients had phototoxic reactions requiring clinic evaluation and treatment. All but two patients reported swallowing problems lasting a median of four weeks, and weight loss (median 6.8 kg). All patients indicated they would again choose photodynamic therapy if they were faced with a similar choice of endoscopic treatment versus surgery for Barrett's esophagus with high-grade dysplasia. These results indicate a generally high level of satisfaction in patients who have been treated with porfimer sodium photodynamic therapy for Barrett's esophagus with high-grade dysplasia.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use
  • Barrett Esophagus / drug therapy*
  • Dihematoporphyrin Ether / therapeutic use
  • Esophageal Neoplasms / drug therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Satisfaction*
  • Photochemotherapy / methods*
  • Precancerous Conditions / drug therapy*
  • Surveys and Questionnaires

Substances

  • Antineoplastic Agents
  • Dihematoporphyrin Ether